ChalliceBonifantMDPhD

Pediatric Hematologic Oncology

Assistant Professor of Oncology and Pediatrics

Dr. Bonifant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1800 Orleans Street
Bloomberg 11N
Baltimore, MD 21287
Phone+1 410-955-8751

Fax+1 410-614-1802

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Johns Hopkins UniversityResidency, Pediatrics, 2009 - 2012
Georgetown University School of MedicineClass of 2009

PubMed

Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality.
Ruyan Rahnama, Monika Kizerwetter, Huilin Yang, Ilias Christodoulou, Christian Guaraca
Journal for Immunotherapy of Cancer. 2025-02-06
1 citations
EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy.
Dua'a Zandaki, Subodh Selukar, Yu Bi, Ying Li, Megan Zinsky
Blood Advances. 2025-01-28
Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain.
Stamatia C Vorri, Natalie J Holl, Michael Leeming, Petya Apostolova, Andrew Marple
Cancer Research Communications. 2024-09-01

Abstracts/Posters

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells
Challice L. Bonifant, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Transgenic Expression of IL15 in CD123-Specific BiTE-Secreting Engager T-Cells Results in Improved Anti-AML Activity
Challice L. Bonifant, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019